Blog

The Brazilian Health Regulatory Agency (ANVISA) has published RDC No. 938/2024, establishing new provisions for Good Storage Practices (GSP) and...

We are thrilled to announce that Brisa Advisors will be attending MEDICA 2024, the world’s largest event in the medical...

The Brazilian Health Regulatory Agency (ANVISA) has established clear guidelines for the compassionate use of medical devices in Brazil through...

ANVISA (National Health Surveillance Agency) is the regulatory body responsible for ensuring the safety of products that impact public health...

Expanding your operations into the Brazilian market is an excellent opportunity for companies in the health, cosmetics, food, and pharmaceutical...

Introduction  Registering medical devices with ANVISA is a fundamental requirement to ensure the technical compliance and safety of products available...

In today’s business environment, many companies are seeking more efficient ways to manage their regulatory compliance functions. The growing complexity...

Patient safety is one of the cornerstones of healthcare. The National Health Surveillance Agency (ANVISA), as the regulatory body responsible...

The regulation of medical products and devices is essential to ensure safety and efficacy in healthcare. In this context, the...